What is it about?
Anti-D-immunoglobuline (anti-D-Ig) is used to prevent development of RhD-antibodies during pregnancy and delivery. Anti-D-Ig is produced from the plasma of women who developed RhD-antibodies during pregnancy and delivery. Thanks to the prevention programme, the number of potential anti-D donors is decreasing. Therefore, it is important to recrute a substantial part of the women with RhD-antibodies. We studied the motivations and barriers of RhD-immunised women to become anti-D donor.
Featured Image
Why is it important?
Knowledge about motivations and barriers to become anti-D donor is necessary for bloodbanks to develop a targeted strategy to recruite potential anti-D donors.
Perspectives
We were surprised to find that the main barrier for anti-D donorship was a lack of knowledge about the need for anti-D donors and the possibility to donate plasma.
Joke Koelewijn
Sanquin Bloedvoorziening
Read the Original
This page is a summary of: Facilitators and barriers for RhD-immunized women to become and remain anti-D donors, Transfusion, March 2018, Wiley,
DOI: 10.1111/trf.14490.
You can read the full text:
Contributors
The following have contributed to this page
